Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 581,892 |
|
|||||
| News | - | ||||||
| Day High | 1.15 | Low High |
|||||
| Day Low | 1.01 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| IceCure Medical Ltd | ICCM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.05 | -4.59% | 1.04 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.05 | 1.01 | 1.15 | 1.03 | 1.09 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,737 | 581,892 | US$ 1.05 | US$ 611,135 | - | 0.52 - 4.73 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:58:09 | formt | 399 | US$ 1.04 | USD |
IceCure Medical Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 46.99M | 45.62M | - | 3.09M | -16.98M | -0.37 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
IceCure Medical News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ICCM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.74 | 1.49 | 0.73 | 1.34 | 21,164,694 | 0.30 | 40.54% |
| 1 Month | 0.80 | 1.49 | 0.701 | 1.32 | 5,681,237 | 0.24 | 30.0% |
| 3 Months | 1.16 | 1.49 | 0.52 | 1.05 | 4,475,673 | -0.12 | -10.34% |
| 6 Months | 1.06 | 1.49 | 0.52 | 1.05 | 2,162,430 | -0.02 | -1.89% |
| 1 Year | 1.10 | 4.73 | 0.52 | 1.52 | 1,863,281 | -0.06 | -5.45% |
| 3 Years | 11.88 | 12.40 | 0.52 | 1.58 | 925,979 | -10.84 | -91.25% |
| 5 Years | 11.88 | 12.40 | 0.52 | 1.58 | 925,979 | -10.84 | -91.25% |
IceCure Medical Description
| Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications. |
